Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Cord Blood Stem Cells for Autism
NCT01638819Phase 2Completed
- Sponsor
- Sutter Health
- Start
- Aug 2012
- Primary completion
- Dec 2015
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous umbilical cord blood in Autism Spectrum Disorder (ASD), sponsored by Sutter Health. Started Aug 2012; status: completed.
02
Drugs
autologous umbilical cord blood
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT01638819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01638819.